Cargando…

Strategies for the Treatment of Parkinson’s Disease: Beyond Dopamine

Parkinson’s disease (PD) is the second-leading cause of dementia and is characterized by a progressive loss of dopaminergic neurons in the substantia nigra alongside the presence of intraneuronal α-synuclein-positive inclusions. Therapies to date have been directed to the restoration of the dopamine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iarkov, Alexandre, Barreto, George E., Grizzell, J. Alex, Echeverria, Valentina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006457/ https://www.ncbi.nlm.nih.gov/pubmed/32076403 http://dx.doi.org/10.3389/fnagi.2020.00004

Ejemplares similares

Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson’s disease
por: Barreto, George E., et al.
Publicado: (2015)

Cholinergic Receptor Modulation as a Target for Preventing Dementia in Parkinson’s Disease
por: Iarkov, Alexandre, et al.
Publicado: (2021)

Cotinine halts the advance of Alzheimer's disease-like pathology and associated depressive-like behavior in Tg6799 mice
por: Patel, Sagar, et al.
Publicado: (2014)

Nicotinic acetylcholine receptors and learning and memory deficits in Neuroinflammatory diseases
por: Echeverria, Valentina, et al.
Publicado: (2023)

Cotinine Plus Krill Oil Decreased Depressive Behavior, and Increased Astrocytes Survival in the Hippocampus of Mice Subjected to Restraint Stress
por: Mendoza, Cristhian, et al.
Publicado: (2018)

Cotinine Enhances Fear Extinction and Astrocyte Survival by Mechanisms Involving the Nicotinic Acetylcholine Receptors Signaling
por: Oliveros-Matus, Patricia, et al.
Publicado: (2020)

Effects of dopamine on reinforcement learning and consolidation in Parkinson’s disease
por: Grogan, John P, et al.
Publicado: (2017)

Dopamine and the Biology of Creativity: Lessons from Parkinson’s Disease
por: Lhommée, Eugénie, et al.
Publicado: (2014)

Habitual behavior and dopamine cell vulnerability in Parkinson disease
por: Hernández, Ledia F., et al.
Publicado: (2015)

Treatment of sleeping disorders should be considered in clinical management of Parkinson's disease
por: dos Santos, Altair Brito, et al.
Publicado: (2014)

The degeneration and replacement of dopamine cells in Parkinson’s disease: the role of aging
por: Rodriguez, Manuel, et al.
Publicado: (2014)

Corrigendum: Habitual Behavior and Dopamine Cell Vulnerability in Parkinson Disease
por: Hernández, Ledia F., et al.
Publicado: (2015)

Exercise-Induced Neuroprotection of the Nigrostriatal Dopamine System in Parkinson's Disease
por: Hou, Lijuan, et al.
Publicado: (2017)

Dopamine and Acetylcholine, a Circuit Point of View in Parkinson’s Disease
por: Rizzi, Giorgio, et al.
Publicado: (2017)

Effects of Dopamine Medication on Sequence Learning with Stochastic Feedback in Parkinson's Disease
por: Seo, Moonsang, et al.
Publicado: (2010)

Calcium, Dopamine and Neuronal Calcium Sensor 1: Their Contribution to Parkinson’s Disease
por: Catoni, Cristina, et al.
Publicado: (2019)

Beyond Dopamine: GABA, Glutamate, and the Axial Symptoms of Parkinson Disease
por: O'Gorman Tuura, Ruth L., et al.
Publicado: (2018)

Brain Dopamine Transmission in Health and Parkinson's Disease: Modulation of Synaptic Transmission and Plasticity Through Volume Transmission and Dopamine Heteroreceptors
por: Borroto-Escuela, Dasiel O., et al.
Publicado: (2018)

Rodent models of Parkinson's disease: beyond the motor symptomatology
por: Campos, Filipa L., et al.
Publicado: (2013)

Involvement of dopamine loss in extrastriatal basal ganglia nuclei in the pathophysiology of Parkinson’s disease
por: Benazzouz, Abdelhamid, et al.
Publicado: (2014)

The role of dopamine in risk taking: a specific look at Parkinson’s disease and gambling
por: Clark, Crystal A., et al.
Publicado: (2014)

Modulation of the glutamatergic transmission by Dopamine: a focus on Parkinson, Huntington and Addiction diseases
por: Gardoni, Fabrizio, et al.
Publicado: (2015)

Dopamine and eye movement control in Parkinson’s disease: deficits in corollary discharge signals?
por: Railo, Henry, et al.
Publicado: (2018)

Correlation between Dopamine Transporter Degradation and Striatocortical Network Alteration in Parkinson’s Disease
por: Lin, Wei-Che, et al.
Publicado: (2017)

Dopamine Replacement Therapy, Learning and Reward Prediction in Parkinson’s Disease: Implications for Rehabilitation
por: Ferrazzoli, Davide, et al.
Publicado: (2016)

The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson's disease
por: Pissadaki, Eleftheria K., et al.
Publicado: (2013)

Beyond reward prediction errors: the role of dopamine in movement kinematics
por: Barter, Joseph W., et al.
Publicado: (2015)

Subcortical Dopamine and Cognition in Schizophrenia: Looking Beyond Psychosis in Preclinical Models
por: Conn, Kyna-Anne, et al.
Publicado: (2020)

Dilated Perivascular Space in the Midbrain May Reflect Dopamine Neuronal Degeneration in Parkinson’s Disease
por: Li, Yanxuan, et al.
Publicado: (2020)

Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test
por: da Conceição, Fabio S.L., et al.
Publicado: (2010)

Can Interactions Between α-Synuclein, Dopamine and Calcium Explain Selective Neurodegeneration in Parkinson's Disease?
por: Post, Michael R., et al.
Publicado: (2018)

Kinetic Modeling of pH-Dependent Oxidation of Dopamine by Iron and Its Relevance to Parkinson's Disease
por: Sun, Yingying, et al.
Publicado: (2018)

Motivational and myopic mechanisms underlying dopamine medication-induced impulsive-compulsive behaviors in Parkinson's disease
por: Dawson, Andrew, et al.
Publicado: (2023)

Beyond the Dopamine Receptor: Regulation and Roles of Serine/Threonine Protein Phosphatases
por: Walaas, Sven Ivar, et al.
Publicado: (2011)

Beyond cAMP: The Regulation of Akt and GSK3 by Dopamine Receptors
por: Beaulieu, Jean-Martin, et al.
Publicado: (2011)

Dopamine-Related Reduction of Semantic Spreading Activation in Patients With Parkinson’s Disease
por: Tiedt, Hannes Ole, et al.
Publicado: (2022)

Testosterone Protects Mitochondrial Function and Regulates Neuroglobin Expression in Astrocytic Cells Exposed to Glucose Deprivation
por: Toro-Urrego, Nicolas, et al.
Publicado: (2016)

The treatment of Parkinson's disease with dopamine agonists
por: Konta, Brigitte, et al.
Publicado: (2008)

Activity of a vmPFC-DRN Pathway Corresponds With Resistance to Acute Social Defeat Stress
por: Grizzell, J. Alex, et al.
Publicado: (2020)

Retinal Ganglion Cells and Circadian Rhythms in Alzheimer’s Disease, Parkinson’s Disease, and Beyond
por: La Morgia, Chiara, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ofc9kcmot8vsv8obvf4vv8uhqg